Gujarat Themis Biosyn board to consider fund raising on Jun 19
Gujarat Themis Biosyn Limited's board will meet on June 19, 2026, to consider raising funds through equity shares and debentures. The proposal includes preferential issues and private placements, subject to regulatory and shareholder approvals.

*this image is generated using AI for illustrative purposes only.
Gujarat Themis Biosyn Limited has scheduled a meeting of its Board of Directors on June 19, 2026, to evaluate a proposal for raising funds. The board will consider issuing equity shares or various securities, including Compulsory Convertible Debentures, Optionally Convertible Debentures, and Non-Convertible Debentures. The proposed fund raising may be conducted through a preferential issue on a private placement basis or any other permissible manner.
The company intends to undertake this issuance in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013. The execution of the proposal remains subject to necessary approvals, including those from the shareholders of the company and the relevant stock exchanges.
Key Agenda Items
The Board meeting will focus on the following primary objective:
- Evaluation of fund raising: Assessing the proposal to raise capital through equity shares or debt instruments.
Proposed Instruments
The company has identified specific financial instruments for potential issuance:
| Instrument Type | Description |
|---|---|
| Equity Shares | Shares to be issued potentially via preferential allotment. |
| Compulsory Convertible Debentures | Debt instruments that mandatorily convert into equity. |
| Optionally Convertible Debentures | Debt instruments with an option to convert into equity. |
| Non-Convertible Debentures | Pure debt instruments without an equity conversion option. |
The intimation regarding the board meeting was submitted to the BSE Limited and the National Stock Exchange of India Limited under Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Historical Stock Returns for Gujarat Themis Biosyn
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.69% | -5.81% | +2.24% | -3.06% | +9.26% | +55.51% |
What specific capital requirements or expansion plans is Gujarat Themis Biosyn aiming to support with this fund raise?
How will the potential dilution of equity impact existing shareholders if the company opts for convertible instruments?
What is the company's current debt-to-equity ratio, and how might issuing Non-Convertible Debentures affect its leverage?


































